Small-area incidence trends in breast cancer

Epidemiology

Volumn 15, Issue 3, 2004, Pages 300-307

  Schootman, Mario ^a,c   Sun, Dongchu ^b  

^a BARNES JEWISH HOSPITAL   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

^c WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BAYES THEOREM; BREAST CANCER; CANCER INCIDENCE; CANCER INVASION; CANCER SCREENING; CARCINOMA IN SITU; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; PRIORITY JOURNAL; UNITED STATES; AGE DISTRIBUTION; BREAST TUMOR; CANCER REGISTRY; COMPARATIVE STUDY; HEALTH SURVEY; INCIDENCE; MASS SCREENING; MIDDLE AGED; MONTE CARLO METHOD; REGISTER; RISK ASSESSMENT; RURAL POPULATION; SENSITIVITY AND SPECIFICITY; SURVIVAL; THEORETICAL MODEL;

ADULT; AGE DISTRIBUTION; AGED; BREAST NEOPLASMS; FEMALE; HUMANS; INCIDENCE; IOWA; MASS SCREENING; MIDDLE AGED; MODELS, THEORETICAL; MONTE CARLO METHOD; POPULATION SURVEILLANCE; REGISTRIES; RISK ASSESSMENT; RURAL POPULATION; SEER PROGRAM; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS;

EID: 3142732208     PISSN: 10443983     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ede.0000121605.41388.7c     Document Type: Article

References (51)

1. Jemal A, Thomas A, Murray T, Thun M. Cancer statistics, 2002. CA Cancer J Clin. 2002;52:23-47.
2. Blackman DK, Bennett EM, Miller DS. Trends in self-reported use of mammograms (1989-1997) and Papanicolaou tests (1991-1997)-Behavioral Risk Factor Surveillance System. MMWR Surveill Summ. 1999; 48:1-22.
3. Delaney G, Ung O, Bilous M, Cahill S, Greenberg M, Boyages J. Ductal carcinoma in situ. Part I: definition and diagnosis. Aust N Z J Surg. 1997;67:81-93.
4. Howe HL, Wingo PA, Thun MJ, et al. Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends. J Natl Cancer Inst. 2001;93:824-842.
5. Chu KC, Tarone RE, Kessler LG, et al. Recent trends in US breast cancer incidence, survival, and mortality rates. J Natl Cancer Inst. 1996;88:1571-1579.
6. Lantz PM, Remington PL, Newcomb PA. Mammography screening and increased incidence of breast cancer in Wisconsin. J Natl Cancer Inst. 1991;6:1540-1546.
7. Devesa S. Cancer patterns among women in the United States. Semin Oncol Nurs. 1995;11:78-87.
8. Adams-Cameron M, Gilliland FD, Hunt WC, Key CR. Trends in incidence and treatment for ductal carcinoma in situ in Hispanic, American Indian, and Non-Hispanic white women in New Mexico, 1973-1994. Cancer. 1999;85:1084-1090.
9. Choi WS, Parker BA, Pierce JP, Greenberg ER. Regional differences in the incidence and treatment of carcinoma in-situ of the breast. Cancer Epidemiol Biomarkers Prev. 1996;5:317-320.
10. Armstrong W, Borman B. Breast cancer in New Zealand: trends, patterns, and data quality. N Z Med J. 1996;109:221-224.
11. Jani AB, Vaida F, Hanks G, et al. Changing face and different countenances of prostate cancer: racial and geographic differences in prostate-specific antigen (PSA), stage, and grade trends in the PSA era. Int J Cancer. 2001;96:363-371.
12. De Angelis R, Valente F, Frova L, et al. Trends of colorectal cancer incidence and prevalence in Italian regions. Tumori. 1998;84:1-8.
13. Bernardinelli L, Montomoli C. Empirical Bayes versus fully Bayesian analysis of geographical variation in disease risk. Stat Med. 1992;11: 983-1007.
14. Clayton DG, Bernardinelli L. Bayesian methods for mapping disease risk. In: Cuzick J, Elliott P, eds. Small Area Studies in Geographical and Environmental Epidemiology. Oxford, UK: Oxford University Press; 1993.
15. Gelfand AE, Smith AFM. Sampling based approaches to calculating marginal densities. J Am Stat Assoc. 1990;85:398-405.
16. Tanner MA, ed. Tools for Statistical Inference: Observed and Data Augmentation Methods. Lecture Notes in Statistics. New York: Springer Verlag; 1993.
17. Lawson AB, Clarke A. Spatial mixture relative risk models applied to disease mapping. Stat Med. 2002;21:359-370.
18. Bernardinelli L, Clayton D, Montomoli C. Bayesian estimates if disease maps: how important are priors. Stat Med. 1995;14:2411-2431.
19. Bernardinelli L, Clayton D, Pascutto C, Montomoli C, Ghislandi M, Songini M. Bayesian analysis of space-time variation in disease risk. Stat Med. 1995;14:2433-2443.
20. Waller LA, Carlin BP, Xia H, Gelfand AE. Hierarchical spatio-temporal mapping of disease rates. J Am Stat Assoc. 1997;92:607-617.
21. Pickle LW. Exploring spatio-temporal patterns of mortality using mixed effects models. Stat Med. 2000;19:2251-2263.
22. MacNab YC, Dean CB. Spatio-temporal modeling of rates for the construction of disease maps. Stat Med. 2002;21:347-358.
23. Kleinschmidt I, Sharp B, Mueller I, Vounatsou P. Rise in malaria incidence in South Africa: A small-area spatial analysis of variation in time trends. Am J Epidemiol. 2002;155:257-264.
24. Sun D, Tsutakawa RK, Kim H, He Z. Spatio-temporal interaction with disease mapping. Stat Med. 2000;19:2015-2035.
25. Kerlikowske K, Grady D, Rubin SM, Sandrock C, Ernster VL. Efficacy of screening mammography: a meta-analysis. JAMA. 1995;273:149-254.
26. US Preventive Services Task Force. Guide to Clinical Preventive Services, 2nd ed. Alexandria, VA: International Medical Publishing; 1996.
27. Gotzsche PC, Olsen O. Is screening for breast cancer with mammography justifiable. Lancet. 2000;355:129-134.
28. Gotzsche PC. Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality (commentary). Cancer. 2002;94:578.
29. Olsen O. Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality (commentary). Cancer. 2002;94:578-579.
30. Ponzone R, Baum M. Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality (commentary). Cancer. 2002;94:579-580.
31. Kopans DB. Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality (commentary). Cancer. 2002;94:580-581.
32. Tabar L, Duffy S. Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality (commentary). Cancer. 2002;94:581-583.
33. UK Trial of Early Detection Breast Cancer Group. 16-year mortality from breast cancer in the UK trial of early detection of breast cancer. Lancet. 1999;353:1990-1914.
34. Alexander FE, Anderson TJ, Brown HK, et al. 14 years of follow-up from the Edinburgh randomised trial of breast cancer screening. Lancet. 1999;353:1903-1908.
35. Sun D, Tsutakawa RK, Speckman PL. Bayesian inference for CAR (1) models with noninformative priors. Biometrika, 1999;86:341-350.
36. Waller LA, Carlin BP, Xia H. Structuring correlation within hierarchical spatiotemporal models for disease rates. In: Gregore TG, Brillinger DR, Diggle PJ, Russek-Cohen E, Warren WG, Woldinger RD, eds. Modeling Longitudinal and Spatially Correlated Data: Lecture Notes in Statistics 122. New York: Springer Verlag; 1997:309-319.
37. Besag J, York J, Mollie A. Bayesian image restoration with two applications in spatial statistics. Annals of the Institute of Statistical Mathematics. 1991;43:1-59.
38. Besag J. Spatial interaction and the statistical analysis of lattice systems (with discussion). J R Stat Soc Ser B, Method. 1974;36:192-236.
39. Besag J, Kooperberg C. On conditional and intrinsic autoregressions. Biometrika. 1995;82:733-746.
40. Speckman PL, Sun D. Bayesian nonparametric regression and autoregression priors. Biometrika. 2003;90:289-302.
41. MacNab Y. Hierarchical Bayesian spatial modelling of small-area rates of non-rare disease. Stat Med. 2003;22:1761-1773.
42. Gelman A, Rubin DB. Inference from iterative simulation using multiple sequences. Stat Sci. 1992;7:457-511.
43. Wakefield J, Best N, Waller L. Bayesian approaches to disease mapping. In: Elliott P, Wakefield J, Best N, Briggs D, eds. Spatial Epidemiology. Oxford: Oxford University Press; 2000:104-127.
44. Feuer EJ, Wun LM. How much of the recent rise in breast cancer incidence can be explained by increases in mammography utilization? A dynamic population model approach. Am J Epidemiol. 1992;136:1423-1436.
45. Prehn AW, Clarke C, Topol B, Glaser S, West D. Increase in breast cancer incidence in middle-aged women during the 1990s. Ann Epidemiol. 2002;12:476-481.
46. Laden F, Speigelman D, Neas LM, et al. Geographic variation in breast cancer incidence rates in a cohort of US women. J Natl Cancer Inst. 1997;89:1373-1378.
47. Safe HS. Xenoestrogens and breast cancer. N Engl J Med. 1997;337: 1303-1304.
48. Gammon MD, Wolff MS, Neugut AI, et al. Environmental toxins and breast cancer on Long Island. II. Organochlorine compound levels in blood. Cancer Epidemiol Biomarkers Prev. 2002;11:686-697.
49. Gammon MD, Santella RM, Neugut AI, et al. Environmental toxins and breast cancer on Long Island. I. Polycyclic aromatic hydrocarbon DNA adducts. Cancer Epidemiol Biomarkers Prev. 2002;11:677-685.
50. Toledano MB, Jarup L, Best N, Wakefield J, Elliott P. Spatial variation and temporal trends of testicular cancer in Great Britain. Br J Cancer. 2001;84:1482-1487.
51. Kafadar K. Geographic trends in prostate cancer mortality: an application of spatial smoothers and the need for adjustment. Ann Epidemiol. 1997;7:35-45.